Abstract:Pancreas transplantation has gained clinical acceptance since its initial application more than 30 years ago. A constellation of surgical, pharmacologic, and metabolic alterations occur with transplantation, particularly if pancreatic transplantation is performed in addition to renal transplantation in a uremic diabetic. Increasingly sophisticated studies have allowed analysis of the performance of the transplanted organ and have enhanced our basic understanding of insulin's complex interplay in peripheral glucoregulatory processes.
Article:Clinical experience with pancreas transplantation was not overwhelmingly successful during the late 1960s and early 1970s [1]. Over the next 20 years a period of constant reevaluation and reassessment of early clinical failures resulted in the development of animal models of transplantation. These models ultimately led to advances in surgical techniques and immunosuppression therapy and provided a better understanding of the impact of surgically induced alterations to the pancreas on carbohydrate metabolism. As pancreas transplantation enjoyed an increasing success rate and longer patient survival, posttransplant graft physiology and the metabolic response to the new insulin source became an interesting area of research.EARLY MODELS OF TRANSPLANTATION Surgical alterations of the pancreas that occur during transplantation include (1) reduction of the beta cell mass (by resection, immunologic loss, or preservation ischemic loss); (2) systemic venous drainage versus portal venous drainage of the pancreatic venous effluent; and (3) denervation. Surgical alterations per se should lead to an altered insulin source. What effect, if any, might this have on peripheral levels of insulin or insulin's glucoregulatory properties? Would it ultimately affect the function of the transplanted pancreas? To address these questions and attempt to delineate the role of surgical alterations of the pancreas on longterm glucose homeostasis in transplanted patients, studies were performed using primarily dog or rat models.
Reduction of Beta Cell MassThe complex interplay between insulin secretion and insulin action was suggested nearly 50 years ago by Dragstedt et al.'s observation that the amount of insulin required to control glucosuria after partial pancreatectomy exceeded the amount needed after complete pancreatectomy [2]. Subsequently, it became evident that surgical models of partial pancreatectomy might result in alterations of alpha and beta cell ratios, which could explain earlier observations. Studies evaluating a dog model of 60% to 80% partial pancreatectomy showed that these animals have a reduced insulin response to the intravenous glucose tolerance test (IVGTT) and altered potassium values, indicating altered glucose metabolism [3]. It was suggested that